March 4 () - Ozempic, Mounjaro and other GLP-1 drugs for diabetes can prevent the formation of new substance use disorders ...
The U.S. Food and Drug Administration has warned Novo Nordisk over a consumer ad for its blockbuster diabetes drug, ...
Novo Nordisk (NVO) stock is in focus as Aspen Pharmacare expects Canada to approve its generic Ozempic by September. Read ...
Aspen Pharmacare's unbranded version of Novo Nordisk's popular diabetes drug Ozempic could be registered in Canada in the ...
Ozempic (R) was approved by Health Canada in 2018. Ozempic (R) is indicated for the once-weekly treatment of adult patients with type 2 diabetes mellitus to improve glycemic control.
Novo Nordisk is investing in a facility in Ireland as it expands its production capacities of the newly launched Wegovy pill, the Danish drugmaker said Monday.
Direct-to-consumer drug advertising has long been opposed by the American Medical Association — and now the Trump ...
Novo Nordisk announced today that Health Canada has approved Ozempic® (semaglutide injection) to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction ...
The market for weight-loss drugs is booming - but the pioneer in the field is shedding profits and share value, writes Adam Maguire ...
Novo Nordisk is repriced as if its fundamentals have sharply deteriorated, despite strong underlying demand. Learn why NVO stock is rated a buy.
Feb 26 () - Eli Lilly on Thursday released new data from a head-to-head trial of its experimental weight-loss pill, ...
Eli Lilly released new data on its oral pill, orforglipron, Thursday, showing it's almost as good as Ozempic. The pill may be available this spring.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results